Learn More
Invitrogen™ LentiArray™ CRISPR Positive Control Lentivirus, human HPRT
Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system.
396.00 EUR - 1726.00 EUR
Specifications
Control Type | Positive Control |
---|---|
Delivery Type | Lentiviral |
Promoter | U6 |
Transfection Technique | Lentiviral transduction |
Species | Human |
Alert:
For Research Use Only. Not for use in diagnostic procedures.
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
15960353
|
Invitrogen™
A32056 |
100 μL |
396.00 EUR
100µL |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
15900383
|
Invitrogen™
A32829 |
1 mL |
1726.00 EUR
1mL |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system. The Invitrogen™ LentiArray™ CRISPR Positive Control Lentivirus gRNA against HPRT is a highly efficient gRNA validated in multiple human cell lines that has achieved editing efficiencies of greater than 80%. It can be used to rapidly determine ideal delivery conditions in order to achieve maximum editing efficiency in your cell model of choice.
The Invitrogen™ LentiArray™ CRISPR Positive Control Lentivirus gRNA against HPRT is a highly efficient gRNA validated in multiple human cell lines that has achieved editing efficiencies of greater than 80%. It can be used to rapidly determine ideal delivery conditions in order to achieve maximum editing efficiency in your cell model of choice.
Specifications
Positive Control | |
U6 | |
Human | |
LentiArray™ |
Lentiviral | |
Lentiviral transduction | |
CRISPR gene knockout | |
Dry Ice |
For Research Use Only. Not for use in diagnostic procedures.